Prometheon Pharma

Prometheon Pharma's patented transdermal platform technology passively delivers large molecule drugs such as insulin, which will increase access to global healthcare opportunities, expand existing markets, and create new preventive markets. Prometheon Pharma has developed a transdermal platform technology called Topicon™, specifically designed for creating drug patch products.